MIFH
TMO icon

Migdal Insurance & Financial Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47
Closed -$23K – 434
2025
Q1 		$23K Buy
+47
New +$25.5K ﹤0.01% 342
2024
Q4 		– Sell
-82
Closed -$51K – 478
2024
Q3 		$51K Sell
82
-8
-9% -$4.74K ﹤0.01% 259
2024
Q2 		$50K Buy
+90
New +$51.6K ﹤0.01% 299
2024
Q1 		– Sell
-2,078
Closed -$1.11M – 485
2023
Q4 		$1.11M Buy
2,078
+1,719
+479% +$832K 0.02% 155
2023
Q3 		$181K Buy
+359
New +$191K ﹤0.01% 234
2022
Q3 		– Sell
-125
Closed -$68K – 611
2022
Q2 		$68K Buy
+125
New +$68.8K ﹤0.01% 347
2022
Q1 		– Sell
-130
Closed -$87K – 692
2021
Q4 		$87K Buy
130
+65
+100% +$40.6K ﹤0.01% 382
2021
Q3 		$37K Sell
65
-20
-24% -$11K ﹤0.01% 494
2021
Q2 		$43K Buy
85
+29
+52% +$13.7K ﹤0.01% 481
2021
Q1 		$26K Buy
+56
New +$26.7K ﹤0.01% 598
2020
Q4 		– Sell
-3,037
Closed -$1.34M – 731
2020
Q3 		$1.34M Sell
3,037
-2,728
-47% -$1.13M 0.02% 246
2020
Q2 		$2.09M Buy
5,765
+1,803
+46% +$604K 0.03% 176
2020
Q1 		$1.12M Sell
3,962
-452
-10% -$143K 0.03% 161
2019
Q4 		$1.43M Buy
4,414
+613
+16% +$186K 0.03% 177
2019
Q3 		$1.11M Buy
3,801
+709
+23% +$203K 0.02% 234
2019
Q2 		$908K Buy
3,092
+740
+31% +$204K 0.02% 251
2019
Q1 		$644K Buy
2,352
+2,004
+576% +$499K 0.02% 266
2018
Q4 		$78K Sell
348
-2,525
-88% -$592K ﹤0.01% 509
2018
Q3 		$701K Buy
2,873
+1,701
+145% +$391K 0.01% 328
2018
Q2 		$243K Buy
1,172
+1,135
+3,068% +$241K 0.01% 415
2018
Q1 		$8K Buy
+37
New +$7.77K ﹤0.01% 561
2017
Q3 		– Sell
-350
Closed -$61K – 578
2017
Q2 		$61K Hold
350
– – ﹤0.01% 380
2017
Q1 		$54K Hold
350
– – ﹤0.01% 385
2016
Q4 		$50K Buy
+350
New +$51.6K ﹤0.01% 351

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Migdal Insurance & Financial Holdings's TMO Position: Q2 2025 in Review

Migdal Insurance & Financial Holdings sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 47 shares — an estimated $23K sold.

Migdal Insurance & Financial Holdings first reported a position in TMO in Q4 2016 and held it in 24 quarters. The position peaked at $2.09M in Q2 2020. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Migdal Insurance & Financial Holdings reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 47 Thermo Fisher Scientific shares in Q2 2025, an estimated $23K.
  • Migdal Insurance & Financial Holdings first reported a position in Thermo Fisher Scientific in Q4 2016 and held it in 24 quarters.
  • Migdal Insurance & Financial Holdings's Thermo Fisher Scientific position peaked at $2.09M in Q2 2020.
  • 2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2025, filed 4 Aug 2025.